Hochheiser, Inga V. http://orcid.org/0000-0001-6649-2624
Pilsl, Michael http://orcid.org/0000-0002-5993-4735
Hagelueken, Gregor
Moecking, Jonas http://orcid.org/0000-0001-5914-1359
Marleaux, Michael
Brinkschulte, Rebecca
Latz, Eicke http://orcid.org/0000-0003-1488-5666
Engel, Christoph http://orcid.org/0000-0001-8451-3599
Geyer, Matthias http://orcid.org/0000-0002-7718-5002
Article History
Received: 14 July 2021
Accepted: 18 January 2022
First Online: 3 February 2022
Competing interests
: M.G. and E.L. are co-founders and consultants of IFM Therapeutics. The other authors declare no competing interests.